Simplex Trading
BIOA

Simplex Trading’s BioAge Labs BIOA Stock Holding History

Simplex Trading’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.6K Sell
2,322
-538
-19% -$10.4K ﹤0.01% 6091
2025
Q4 		$37.8K Buy
2,860
+1,455
+104% +$12.9K ﹤0.01% 5905
2025
Q3 		$8K Sell
1,405
-13,876
-91% -$65K ﹤0.01% 8068
2025
Q2 		$63K Sell
15,281
-6,322
-29% -$25.5K ﹤0.01% 5702
2025
Q1 		$81K Buy
+21,603
New +$99.9K ﹤0.01% 5288

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Simplex Trading's BIOA Position: Q1 2026 in Review

Simplex Trading reduced its BioAge Labs (BIOA) stake by 19% in Q1 2026, selling an estimated $10.4K and leaving 2,322 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6091.

Simplex Trading first reported a position in BIOA in Q1 2025 and has held it in 5 quarters since. The position peaked at $81K in Q1 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Simplex Trading held 2,322 shares of BioAge Labs worth $40.6K as of Q1 2026.
  • Simplex Trading sold 538 BioAge Labs shares in Q1 2026, an estimated $10.4K.
  • BioAge Labs made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6091 holding.
  • Simplex Trading first reported a position in BioAge Labs in Q1 2025 and has held it in 5 quarters since.
  • Simplex Trading's BioAge Labs position peaked at $81K in Q1 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.